Dr. Samuel Meyer recently joined Sami Labs Ltd., Sabinsa's manufacturing and research group in India . Dr. Meyer holds a MD in Pediatrics from the University of Bombay, India. He brings with him over 35 years of medical research and leadership experience in the pharmaceutical industry. He began his career as a medical researcher at Hoechst India (now Aventis) in 1967 and rose to the position of Medical Director. During his 25 years tenure at Hoescht, he was involved in the discovery and introduction of a number of leading therapeutic drugs to the Indian as well as global markets. This included the development of over 25 NDAs (New Drug Applications) . Subsequently, Dr. Meyer was Senior Vice President, Business Development at Cadila Health Care for over 6 years.
Dr. Meyer has served as a medical expert on various governmental and non-governmental committees, and on executive committees of a number of professional societies and associations. He guided the publication of the first "National Essential Drug List of India," and was Vice-Chairman (Medical) of the Organization of Pharmaceutical Producers of India (OPPI) , Chairman (Medical) of Indian Drug Manufacturers Association (IDMA), and was the founder secretary of the Chronobiological society of India . Dr. Meyer has been a visiting lecturer at universities in India and abroad and has authored and peer-reviewed several publications, particularly in the area of Drug Research and Development.
At Sami Labs, Dr. Meyer will work on developing and implementing IND (Investigational New Drug) applications for various products and formulations.
